Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli. [electronic resource]
- Molecular therapy : the journal of the American Society of Gene Therapy Feb 2015
- 278-89 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't